[Editor's note: Complete historical information on important medical device trial announcements is available from Informa’s MedDeviceTracker. For an archive of previous Medtech Insight articles on medtech clinical trials, visit the Tracking Trials page.]
The NILE trial shows Guardant Health Inc.’s Guardant360 cell-free DNA assay is a viable alternative to complete genotyping...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?